JPS59217784A - Aerosol suspension - Google Patents

Aerosol suspension

Info

Publication number
JPS59217784A
JPS59217784A JP58087583A JP8758383A JPS59217784A JP S59217784 A JPS59217784 A JP S59217784A JP 58087583 A JP58087583 A JP 58087583A JP 8758383 A JP8758383 A JP 8758383A JP S59217784 A JPS59217784 A JP S59217784A
Authority
JP
Japan
Prior art keywords
octyldodecyl
suspension
formula
liquefied propellant
solid powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58087583A
Other languages
Japanese (ja)
Other versions
JPH0244350B2 (en
Inventor
Takahiro Shinosawa
篠沢 孝絋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyo Aerosol Industry Co Ltd
Original Assignee
Toyo Aerosol Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyo Aerosol Industry Co Ltd filed Critical Toyo Aerosol Industry Co Ltd
Priority to JP58087583A priority Critical patent/JPS59217784A/en
Publication of JPS59217784A publication Critical patent/JPS59217784A/en
Publication of JPH0244350B2 publication Critical patent/JPH0244350B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)

Abstract

PURPOSE:The titled suspension having improved suspending and dispersing properties, and stability in a wide temperature range, containing a liquefied propellant, solid powder insoluble in it, octyldodecyl oleate, octyldodecyl ricinoleate, etc. as a suspension. CONSTITUTION:The desired suspension containing preferably 50-95wt% liquefied propellant (e.g., trichlorofluoromethane, etc.), 0.5-15wt% solid powder (e.g., talc, benzethonium chloride, etc.) insoluble in it, 0.05-15wt% octyldodecyl oleate shown by the formula I (R is group shown by the formula II), octyldodecyl ricinoleate shown by the formula III and/or octyldodecyl myristate shown by the formula IV as a suspension, and, if necessary, 5-40wt% solvent, to give the desired suspension. EFFECT:Mild to the skin, free from optical toxicity and dangerous toxicity, having no irritation to eye mucosa. USE:Drugs, guasi-drugs, cosmetic, etc.

Description

【発明の詳細な説明】 本発明は、懸濁分散性の改善されたエアゾール懸濁剤に
関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to an aerosol suspension with improved suspension dispersibility.

液化発射剤に不溶性の固形物粉末を界面活性剤又は懸濁
化剤を用いて、液化発射剤中に懸濁分散させ、これを耐
圧性の容器に充填し、容器の噴射孔、ノズルより発射噴
射させることは公知である。しかしエアゾール懸濁剤を
充填したに エアゾール製品、に−!、種々の問題がある。例えばニ
ーアゾール懸濁剤において、液化発射剤中に、噴霧塗布
を目的とする薬剤等の固形物粉末を十分に懸濁分散させ
ることは、一般に困難であって、その懸濁状態の安定性
が小さく懸濁粒子が沈降、浮遊又は凝集するようになる
。このため噴射孔、ノズル、バルブ又はアクチュエータ
ーに詰まりが生じ、あるいは均一な噴霧が阻害されるよ
うになり、また薬剤の効力にも大きな影響を及ぼし、期
待する薬効が十分に得られなくなる。このような傾向は
懸濁させる固形物粉末の量が多いときは一層顕著となる
。これは固形物粉末の粒子が特殊な場合を除き、懸濁操
作後、直ちに分離又は凝集を起こすためである。
A solid powder that is insoluble in the liquefied propellant is suspended and dispersed in the liquefied propellant using a surfactant or a suspending agent, and this is filled into a pressure-resistant container and fired from the injection hole or nozzle of the container. It is known to inject. However, aerosol products filled with aerosol suspension agents, -! , there are various problems. For example, in niazole suspensions, it is generally difficult to sufficiently suspend and disperse solid powders such as drugs intended for spray application in the liquefied propellant, and the stability of the suspension state is low. Suspended particles become sedimented, suspended or agglomerated. As a result, injection holes, nozzles, valves, or actuators become clogged, or uniform spraying becomes obstructed, and the efficacy of the drug is also significantly affected, making it impossible to obtain the desired medicinal efficacy. This tendency becomes more pronounced when the amount of solid powder to be suspended is large. This is because solid powder particles immediately separate or agglomerate after the suspension operation, except in special cases.

したがってエアゾール懸濁剤においては、適当な懸濁化
剤を用いて十分に固形物粉末を懸濁分散させると共にそ
の状態を安定に維持することが必要であり、これによっ
て粒子の沈降、浮上、凝集等を防止し、容器壁への付着
、沈殿の生成、沈殿物の固着等を防止することが必要′
÷ある。
Therefore, in aerosol suspensions, it is necessary to sufficiently suspend and disperse the solid powder using an appropriate suspending agent and maintain that state stably. It is necessary to prevent adhesion to container walls, formation of precipitates, and adhesion of precipitates.
÷There is.

液化発射剤に不溶もしくは難溶の固形物を液化発射剤に
懸濁させることによりエアゾール懸濁剤を得る方法とし
ては、次のものが知られている。
The following methods are known for obtaining an aerosol suspension by suspending a solid substance that is insoluble or poorly soluble in a liquefied propellant.

(1)  Hrfi (、’−水性、親油性の均衡値)
が約1゜以下で、かつ液化発射剤に不一である液状の非
イオン系界i性剤を用いて、液化全身4剤中に固形物を
懸濁させる方法(特公昭56−14697号公報参照)
(1) Hrfi (,'-aqueous, lipophilic equilibrium value)
A method of suspending a solid substance in a liquefied systemic agent using a liquid non-ionic surfactant whose angle is about 1° or less and which is not the same as that of a liquefied propellant (Japanese Patent Publication No. 14697/1983) reference)
.

(2)  レシチン、ラノリン、コレステロール又ハこ
れらの誘導体を低級アルコールと高級脂肪酸のエステル
に溶解したものを用いて、不溶性の固形物を液化発射剤
中に分散させる方法(特公昭40−28956号公報参
照)。
(2) A method of dispersing insoluble solids in a liquefied propellant using lecithin, lanolin, cholesterol, or their derivatives dissolved in lower alcohol and higher fatty acid esters (Japanese Patent Publication No. 40-28956) reference).

(6)液化発射剤に可溶である天然りん脂質及び6− りん酸エステル類と、炭素原子数が11〜20個の室温
で液状の直鎖は側鎖を有する高級アルコールを用いて、
固形物を発射剤に懸濁させる方法(“特公昭42−14
804号公報参照)。
(6) Using natural phospholipids and 6-phosphate esters that are soluble in liquefied propellant, and a higher alcohol having a linear side chain and having 11 to 20 carbon atoms and which is liquid at room temperature,
A method of suspending a solid substance in a propellant (“Special Publication Act
(See Publication No. 804).

(4)多価アルコールの長鎖脂肪酸による部分エステル
のアセチル化物であって、液状のものを用いて、液化発
射剤に不溶性の固形物を懸濁させる方法(特公昭41−
409号公報参照)。
(4) A method of suspending insoluble solids in a liquefied propellant using a liquid acetylated product of a partial ester with a long chain fatty acid of a polyhydric alcohol
(See Publication No. 409).

しかしこれらの方法はいずれも満足すべき効果を奏する
ものではない。これらの方法では常に十分安定な懸濁分
散状態が得られず、実際に用い得る懸濁化剤の種類及び
固形物の種類が限定される。したがって、皮膚に対する
刺激性の強いものの使用を避けるべき人体用エアゾール
においては、従来の方法の適用が困難な場合が多い。例
えば固形物粒子をエステルと共に懸濁分散する場合にお
いてエステルとしては従来イソプロピルミリステート又
はイソプロピルイルミテートが主として用いられている
が、これらは皮膚に対する刺激が強く、また刺激臭があ
り、4− べとつきなどの欠点がある。
However, none of these methods produces satisfactory results. These methods do not always provide a sufficiently stable suspension/dispersion state, and the types of suspending agents and solid materials that can actually be used are limited. Therefore, it is often difficult to apply conventional methods to aerosols for the human body, which should avoid the use of substances that are highly irritating to the skin. For example, when solid particles are suspended and dispersed with an ester, isopropyl myristate or isopropyl illumitate has been mainly used as the ester, but these are highly irritating to the skin, have a pungent odor, and are sticky. There are drawbacks.

本発明者はこの点を改良するため種々研究の結果、多く
の種類の固形物を懸濁分散させ、ることかでき、しかも
安定な懸濁液の得られる懸濁化剤を見出して本発明を完
成した。
In order to improve this point, the present inventor conducted various studies and found a suspending agent that can suspend and disperse many types of solids and provide a stable suspension. completed.

本発明は、液・化発射剤、・己れに不溶の固形物粉末、
及び懸濁化剤としてオレイン酸オクチルドデシル1、リ
シルレイン酸オクチルドデ5シル及び/又はミリスチン
酸オクチルドデシルを含有することを特徴とするエアゾ
ール懸濁剤である。
The present invention provides liquid/condensed propellant, self-insoluble solid powder,
and an aerosol suspension characterized by containing octyldodecyl oleate, octyldodecyl lysyloleate, and/or octyldodecyl myristate as a suspending agent.

本発明のエアゾール懸濁剤は、所望により溶剤例えばエ
タノール等、圧縮ガス例えば炭酸ガス、窒素、−酸化窒
素、ヘリウム等を含有していてもよい。溶剤を含有する
場合の懸濁剤の組成は固形物粉末0.5〜15重量%、
懸濁化剤0゜ましい。
The aerosol suspension of the present invention may optionally contain a solvent such as ethanol, a compressed gas such as carbon dioxide, nitrogen, -nitrogen oxide, helium, etc. When containing a solvent, the composition of the suspending agent is 0.5 to 15% by weight of solid powder;
Suspending agent 0° is preferable.

懸濁化剤として用いられるオレイン酸オクチルドデシル
(A)、リシルイン酸オクチルドデシル(B)及びミリ
スチン酸オクチルドデシル(C)は下記式で表わされる
。これらの式中のRはCH2−C,H,。
Octyldodecyl oleate (A), octyldodecyl lysylinate (B) and octyldodecyl myristate (C) used as suspending agents are represented by the following formula. R in these formulas is CH2-C,H.

−CH2−CH−C,oH2□ を示す。-CH2-CH-C, oH2□ shows.

CH3−(CH2)7−cH=cH−(CH2)7−c
oo−R(A)CH CH3−(CH2)、−CH−CH2−CH=CH−(
CH2)7−Coo−R(B)CH3−(CH2)、2
−Coo−R’       (C)これらの化合物は
、懸濁化剤として優れているほかに下記の特色を有する
。皮膚刺激がほとんと無く、皮膚に対して潤滑性及び柔
軟性を与え、老化防止、殺菌作用を有する。また皮膚に
塗布したときの感触が非常に優れ、べとつきが無く、展
伸性に優れ、さっばりして吸収窓かあり、なじみが良く
、ポロシティ−効果があり、皮膚上で安定で分解するこ
とがな(、臭い、色がほとんどなく、経時的に着色した
り変臭しない。粘度が適度に低く、価格が経済的であり
、皮膚上での微生物による分解もな(、香料に対する溶
解性も大きく、分子量の大きい溶剤であるため表皮のバ
リアー透過性が緩慢で香料の皮膚刺激の緩和に役立つ。
CH3-(CH2)7-cH=cH-(CH2)7-c
oo-R(A)CH CH3-(CH2), -CH-CH2-CH=CH-(
CH2)7-Coo-R(B)CH3-(CH2),2
-Coo-R' (C) In addition to being excellent as a suspending agent, these compounds have the following characteristics. It causes almost no skin irritation, provides lubricity and flexibility to the skin, and has anti-aging and bactericidal effects. It also has a very good feel when applied to the skin, is non-sticky, has excellent spreadability, is light and has an absorption window, blends well, has a porosity effect, is stable on the skin, and decomposes. It has almost no odor or color, and does not change color or odor over time. It has a moderately low viscosity, is economical, and is not decomposed by microorganisms on the skin (and has low solubility in fragrances. Because it is a large solvent with a high molecular weight, it has a slow permeability through the epidermal barrier and is useful for alleviating the skin irritation caused by fragrances.

皮膚、粘膜、頭髪、頭皮等に使用されている化粧品の油
液にみられるような酸敗は起こらず、温度、光線に対し
ても安定性があり、耐熱性も良い。対の溶剤に対しても
混合することも可能である。特に顔料に対しての色別れ
を防止し、展伸性も優れている。
It does not become rancid as seen in cosmetic oils used for the skin, mucous membranes, hair, scalp, etc., and is stable against temperature and light, and has good heat resistance. It is also possible to mix pairs of solvents. In particular, it prevents color separation of pigments and has excellent spreadability.

特に常温で液体であり、凝固点が低く、沸点及び引火点
が高(空気中においても酸化されず安定である。
In particular, it is liquid at room temperature, has a low freezing point, and high boiling and flashing points (it is stable even in air without being oxidized).

固形物粉末としては、例えば下記のものがあげられる。Examples of the solid powder include the following.

プレドニゾロン、ハイドロコーチソン及びこれらの誘導
体、デキサメサゾン、塩酸テトラハイドロゾリン、硫酸
フラジオマイシン、ベンズエトニウムクロライド、アル
ミニウム粉末、カオリン、メルク、アルミニウムクロロ
ハイドロオキサイド粉末、酸化チタン、炭酸マグネシウ
ム、珪酸マグネシウム、魚鱗箔、雲母チタン、マイカ、
殿粉、合成高分子例えばナイロン、ポリエチレン等、ス
テアリン酸のマグネシウム塩、カルシウム塩、アルミニ
ウム塩等、酸化鉄例えばベンガラ等、ベントナイト、カ
ラーペスト、銀粉等。これらの粉末は粒径100μ以下
、特に5〜60μのものが好ましい。゛液化発射剤とし
ては、例えばトリクロロフルオロメタン(Fll)、ジ
クロロジフルオロメタン(Fl2)、クロロフルオロメ
タン(−F22)、1,2−ジクロロ−1,1,2,2
−テトラフルオロエタン(Fll4)、1,1.2−)
ジクロロ−1,2,2−)リフルオロエタン(Fl 1
3 )、1−クロロ−1,1−ジフルオロエタン(F1
42b)、ジメチルエーテル(DME )、液化石油ガ
ス(LP() )などが用いられる。
Prednisolone, hydrocortisone and their derivatives, dexamethasone, tetrahydrozoline hydrochloride, fradiomycin sulfate, benzethonium chloride, aluminum powder, kaolin, Merck, aluminum chlorohydroxide powder, titanium oxide, magnesium carbonate, magnesium silicate, fish scale foil , mica titanium, mica,
Starch, synthetic polymers such as nylon, polyethylene, etc., stearic acid magnesium salts, calcium salts, aluminum salts, etc., iron oxides such as red iron oxide, bentonite, colored pesto, silver powder, etc. These powders preferably have a particle size of 100 microns or less, particularly 5 to 60 microns.゛As the liquefied propellant, for example, trichlorofluoromethane (Fll), dichlorodifluoromethane (Fl2), chlorofluoromethane (-F22), 1,2-dichloro-1,1,2,2
-Tetrafluoroethane (Fll4), 1,1.2-)
Dichloro-1,2,2-)lifluoroethane (Fl 1
3), 1-chloro-1,1-difluoroethane (F1
42b), dimethyl ether (DME), liquefied petroleum gas (LP()), etc. are used.

本発明のエアゾール懸濁剤は、固形物の微粉末及び懸濁
化剤を、加圧下に液化発射剤とともに耐圧容器に充填し
、よく混合することにより得られる。この場合適宜の助
剤又は添加物を加えることもできる。
The aerosol suspension of the present invention can be obtained by filling a fine solid powder and a suspending agent together with a liquefied propellant under pressure in a pressure-resistant container and thoroughly mixing them. In this case, appropriate auxiliaries or additives may also be added.

本発明のエアゾール懸濁剤は極めて安定であって、長時
間放置しても、粉末粒子の沈降、浮遊、凝集等はほとん
ど生じない。また固形物を容易に分散させる゛ことがで
き、広い温度範囲にわたって安定な懸濁分散状態を維持
することができる。
The aerosol suspension of the present invention is extremely stable, and even if left for a long time, the powder particles hardly settle, float, or aggregate. In addition, solid matter can be easily dispersed, and a stable suspension and dispersion state can be maintained over a wide temperature range.

本発明のエアゾール懸濁剤は医薬、医薬部外品、化粧品
等の人体用エアゾールとして好適である。すなわち、懸
濁化剤として用いられるオレイン酸オクチルドデシル、
リシルへン酸オクチルドデシル及びミリスチン酸オクチ
ルドデシルは皮膚に対して温和であって光毒性及び危険
毒性が全くなく、また眼粘膜刺激性もなく、人体に対し
て無害もしくは無毒性である。そのほか皮膚に対してべ
とつきがなく、のびが良く、さらに潤滑性及び柔軟性を
与え、老化防止や湿潤性、殺菌作用を有する。皮膚に対
する調和性はラノリン等より優れたものであり、無臭で
あって不快感を与えることがない。
The aerosol suspension of the present invention is suitable as an aerosol for human bodies such as medicines, quasi-drugs, and cosmetics. That is, octyldodecyl oleate used as a suspending agent,
Octyldodecyl lysylpentate and octyldodecyl myristate are mild to the skin, have no phototoxicity or dangerous toxicity, are not irritating to the eye mucous membrane, and are harmless or non-toxic to the human body. In addition, it is non-sticky to the skin, spreads well, provides lubricity and flexibility, and has anti-aging, moisturizing, and bactericidal effects. Its compatibility with the skin is superior to lanolin and the like, and it is odorless and does not cause discomfort.

実施例1〜15 下記表に示す成分を含有するエアゾール懸濁製剤を製造
し、これを用いて再分散性、流動性及びパル、ブ詰り試
験を行った。
Examples 1 to 15 Aerosol suspension preparations containing the ingredients shown in the table below were manufactured, and redispersibility, fluidity, pulp and clogging tests were conducted using the preparations.

再分散性は、温度35°C1湿度60%寡雰囲気中に5
力月間放置したのち、分散の程度を次のように判定した
The redispersibility is 5% in a low atmosphere at a temperature of 35°C and a humidity of 60%.
After being left for a month, the degree of dispersion was determined as follows.

◎:均一に分散 △:凝集傾向が強い ×:部分的に強い凝集体が生じた ′ 流動性は試料を充填したガラス瓶な王立状態で軽く振り
、内容物の流動状態から次のように判定した。
◎: Uniformly dispersed △: Strong tendency to agglomerate ×: Strong agglomerates were formed in some parts ′ Fluidity was determined by shaking a glass bottle filled with the sample in an upright position, and determining the fluidity of the contents as follows. .

◎:内容物が大きく動く △:  〃  わずかに動く ×:〃  動かない パルプ詰り試験は試料50個を用い、パルプ詰り数を表
に示した。
◎: Content moves a lot △: Slight movement ×: Does not move 50 samples were used in the pulp clogging test, and the number of pulp clogging is shown in the table.

表中の懸濁化剤Aはオレイン績オク゛チルドデシル、B
はリシルイン酸オクチルドデシル、Cはミリスチン酸オ
クチルドデシルを示す。
Suspending agent A in the table is oleic octyldodecyl, B
represents octyldodecyl lysylinate, and C represents octyldodecyl myristate.

−15− 出願人 東洋エアソ一ル工業株式会社-15- Applicant: Toyo Air Sol Industrial Co., Ltd.

Claims (1)

【特許請求の範囲】 1、 液化発射剤、これに不溶の固形物粉末及び懸濁化
剤としてオレイン酸オクチルドデシル、リシルイン酸オ
クチルドデシル及び/又はミリスチン酸オクチルドデシ
ルを含有することを特徴とするエアゾール懸濁剤。 2、 液化発射剤50〜95重量%、固形物粉末0゜5
〜15重量%、懸濁化剤0.05〜15重量%及び所望
により溶剤5〜40重量%を含有する特許請求の範囲第
1項に記載のエアゾール懸濁剤。
[Scope of Claims] 1. An aerosol containing a liquefied propellant, a solid powder insoluble therein, and octyldodecyl oleate, octyldodecyl lysylinate, and/or octyldodecyl myristate as a suspending agent. Suspending agent. 2. Liquefied propellant 50-95% by weight, solid powder 0°5
15. An aerosol suspension according to claim 1, containing from 15% to 15% by weight of a suspending agent, from 0.05 to 15% by weight of a suspending agent and optionally from 5 to 40% by weight of a solvent.
JP58087583A 1983-05-20 1983-05-20 Aerosol suspension Granted JPS59217784A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP58087583A JPS59217784A (en) 1983-05-20 1983-05-20 Aerosol suspension

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58087583A JPS59217784A (en) 1983-05-20 1983-05-20 Aerosol suspension

Publications (2)

Publication Number Publication Date
JPS59217784A true JPS59217784A (en) 1984-12-07
JPH0244350B2 JPH0244350B2 (en) 1990-10-03

Family

ID=13919019

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58087583A Granted JPS59217784A (en) 1983-05-20 1983-05-20 Aerosol suspension

Country Status (1)

Country Link
JP (1) JPS59217784A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536444A (en) * 1993-07-08 1996-07-16 Asta Medica Aktiengesellschaft Compressed-gas packages using polyoxyethylene glyceryl fatty-acid esters as suspension stabilizers and valve lubricants
JP2001226258A (en) * 1999-12-06 2001-08-21 Taisho Pharmaceut Co Ltd Powdery aerosol composition

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536444A (en) * 1993-07-08 1996-07-16 Asta Medica Aktiengesellschaft Compressed-gas packages using polyoxyethylene glyceryl fatty-acid esters as suspension stabilizers and valve lubricants
JP2001226258A (en) * 1999-12-06 2001-08-21 Taisho Pharmaceut Co Ltd Powdery aerosol composition

Also Published As

Publication number Publication date
JPH0244350B2 (en) 1990-10-03

Similar Documents

Publication Publication Date Title
CA1148440A (en) Water-in-air suspension containing dispersible material
AU692815B2 (en) Novel foaming compositions, particularly for rectal foams, and resulting foams
DE68904300T2 (en) MEDICAL AEROSOL FORMULATIONS.
EP1337226A1 (en) Cosmetic or dermatological agent in the form of a creamy permanent mousse or a stable foamed cream
ATE20574T1 (en) POWDER MIXTURE OF LIPID AND HYDROPHOBIC INGREDIENTS, PROCESS FOR THEIR PREPARATION, HYDRATED LAMELLAR LIPID PHASE AND PROCESS FOR THE PREPARATION, PHARMACEUTICAL OR COSMETIC AGENTS CONTAINING HYDRATED LAMELLAR LIPID PHASE.
JPH057062B2 (en)
EP0215903A1 (en) Exothermic stable foam compositions
GB2113706A (en) Aersol antiperspirant composition
JPS59217784A (en) Aerosol suspension
JPH0410918B2 (en)
JPH08245363A (en) Solid o/w-type emulsion cosmetic
JP5922287B1 (en) Oil-wrapping powder composition and method for producing the same
JPS6314706A (en) Oil-in-water type emulsion cosmetic
JPH06321772A (en) Water ribosome system and preparation of said ribosome system
JPS61227517A (en) Skin cosmetic
JP2556730B2 (en) Skin cosmetics
JPS6317112B2 (en)
JP3198460B2 (en) Powder aerosol composition
JPH05279236A (en) Cologne for body
JP7384670B2 (en) powder composition
JP7488047B2 (en) Powder composition
JPS58103301A (en) Powdery aerosol suspension liquid
US4018888A (en) Amine-stabilized dry powder aerosol antiperspirant compositions and method of preparation
JPS6326154B2 (en)
JPH01294615A (en) Two layer type cosmetic